The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modeling and comparison of dissolution profiles
Costa, P., & Sousa Lobo, J. M. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00095-1 · Cited by 5,509
Recent advances on chitosan-based micro- and nanoparticles in drug delivery
Agnihotri, S. A., Mallikarjuna, N. N., & Aminabhavi, T. M. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.010 · Cited by 2,586
Nanosuspensions as particulate drug formulations in therapy
Müller, R. H., Jacobs, C., & Kayser, O. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00118-6 · Cited by 1,370
Biodegradable nanoparticles for drug delivery and targeting
Hans, M. L., & Lowman, A. M. (2002) · Current Opinion in Solid State and Materials Science · doi:10.1016/s1359-0286(02)00117-1 · Cited by 1,324
Tight junctions of the blood–brain barrier
Wolburg, H., & Lippoldt, A. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(02)00200-8 · Cited by 1,183
Nanoparticulate systems for brain delivery of drugs
Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958
Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., & Alyautdin, R. (2002) · Journal of drug targeting · doi:10.1080/10611860290031877 · Cited by 801
Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells
Vinogradov, S. V., Bronich, T. K., & Kabanov, A. V. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00245-9 · Cited by 775
Tau protein pathology in neurodegenerative diseases
Spillantini, M. G., & Goedert, M. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01337-x · Cited by 683
Brain drug delivery of small molecules using immunoliposomes
Huwyler, J., Wu, D., & Pardridge, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14164 · Cited by 656
Design of biodegradable particles for protein delivery
Vila, A., Sánchez, A., Tobı́o, M., Calvo, P., & Alonso, M. J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00486-2 · Cited by 620
Physiology of the CSF and Blood-Brain Barriers
Davson, H., & Segal, M. B. (1996) · Medical Entomology and Zoology · Cited by 582
Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Ivanov, A. A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00023-j · Cited by 539
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521
Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate
Wu, Y., Yang, W., Wang, C., Hu, J., & Fu, S. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.042 · Cited by 517
Colloidal Drug Delivery Systems
Kreuter, J. (2014) · CRC Press eBooks · doi:10.1201/9781498710565 · Cited by 469
Kreuter, J., Ramge, P., Petrov, V., Hamm, S., Gelperina, S. E., Engelhardt, B., Alyautdin, R., von Briesen, H., & Begley, D. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1022604120952 · Cited by 469
Drug-loaded nanoparticles : preparation methods and drug targeting issues
Allémann, É., Gurny, R., & Doelker, É. (1993) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 454
Couvreur, P., Kante, B., Roland, M., Guiot, P., Bauduin, P., & Speiser, P. (1979) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1979.tb13510.x · Cited by 452
Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles
Banerjee, T., Mitra, S., Kumar Singh, A., Kumar Sharma, R., & Maitra, A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00267-3 · Cited by 409
Drug delivery to the central nervous system: A review
Tamargo, R. J., & Brem, H. (1992) · Neurosurgery Quarterly · Cited by 369
Estimated Prevalence of Alzheimer's Disease in the United States
Evans, D. A. (1990) · The Milbank Quarterly · doi:10.2307/3350099 · Cited by 357
Alyautdin, R. N., Petrov, V. E., Langer, K., Berthold, A., Kharkevich, D. A., & Kreuter, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012098005098 · Cited by 352
Efficacy and Safety of Cholinesterase Inhibitors in Alzheimer’s Disease: A Meta-analysis
Lane, C. E., & Conroy, M. L. (2022) · Essential Reviews in Geriatric Psychiatry · doi:10.1007/978-3-030-94960-0_53 · Cited by 324
Colloidal carriers and blood–brain barrier (BBB) translocation: A way to deliver drugs to the brain?
Garcia-Garcia, E., Andrieux, K., Gil, S., & Couvreur, P. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.031 · Cited by 314
Pharmacokinetics and distribution of a biodegradable drug-carrier
Grislain, L., Couvreur, P., Lenaerts, V., Roland, M., Deprez-Decampeneere, D., & Speiser, P. (1983) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(83)90166-7 · Cited by 305
The Blood-brain Barrier: Principles for Targeting Peptides and Drugs to the Central Nervous System
Begley, D. J. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb07112.x · Cited by 291
Greene, J. D. W., Baddeley, A. D., & Hodges, J. R. (1996) · Neuropsychologia · doi:10.1016/0028-3932(95)00151-4 · Cited by 277
Nanoparticle Technology for Delivery of Drugs Across the Blood–Brain Barrier
Schroeder, U., Sommerfeld, P., Ulrich, S., & Sabel, B. A. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980084y · Cited by 275
Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain
Sun, W., Xie, C., Wang, H., & Hu, Y. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.09.087 · Cited by 215
Kreuter, J., Petrov, V. E., Kharkevich, D. A., & Alyautdin, R. N. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00061-8 · Cited by 196
Nasal administration of Carbamazepine using chitosan microspheres: In vitro/in vivo studies
GAVINI, E., HEGGE, A., RASSU, G., SANNA, V, TESTA, C., PIRISINO, G., KARLSEN, J., & GIUNCHEDI, P. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.09.013 · Cited by 170
Tacrine: A pharmacological review
Freeman, S. E., & Dawson, R. M. (1991) · Progress in Neurobiology · doi:10.1016/0301-0082(91)90002-i · Cited by 168
Behan, N. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00286-6 · Cited by 164
Tröster, S. D., Müller, U., & Kreuter, J. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90047-8 · Cited by 161
Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading
Seijo, B., Fattal, E., Roblot-Treupel, L., & Couvreur, P. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90024-x · Cited by 151
Particle size and size distribution of poly(butyl-2-cyanoacrylate) nanoparticles
Douglas, S. J., Illum, L., Davis, S. S., & Krueter, J. (1984) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(84)90015-8 · Cited by 144
Friese, A. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00073-9 · Cited by 139
Price, B. H., Gurvit, H. I., Weıntraub, S., Geula, C., Leimkuhler, E., & Mesulam, M. M. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540090038008 · Cited by 136
Influence of glutaraldehyde on drug release and mucoadhesive properties of chitosan microspheres
Genta, I., Costantini, M., Asti, A., Conti, B., & MONTANARI, L. (1998) · Carbohydrate Polymers · doi:10.1016/s0144-8617(98)00022-8 · Cited by 135
Chiannilkulchai, N., Ammoury, N., Caillou, B., Devissaguet, J. P., & Couvreur, P. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf02897257 · Cited by 130
A Strategy for Delivering Peptides into the Central Nervous System by Sequential Metabolism
Bodor, N. S., Prókai, L., Wu, W.-M., Farag, H. H. A., Sastry, J. S., Kawamura, M., & Simpkins, J. W. (1992) · Science · doi:10.1126/science.1529356 · Cited by 127
On Drawing Impairment in Alzheimer's Disease
Kirk, A., & KERTESZ, A. E. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530130083024 · Cited by 115
Löbenberg, R. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00105-3 · Cited by 109
Borchard, G., Audus, K. L., Shi, F., & Kreuter, J. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90372-7 · Cited by 105
Drug delivery through the blood-brain barrier
Tamai, I., & Tsuji, A. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(96)00011-7 · Cited by 101
Development of a nanoparticle controlled-release formulation for human use
Verdun, C., Couvreur, P., Vranckx, H., Lenaerts, V., & Roland, M. (1986) · Journal of Controlled Release · doi:10.1016/0168-3659(86)90081-7 · Cited by 94
Reddy, L. H., & Murthy, R. S. R. (2004) · Biomedical Papers · doi:10.5507/bp.2004.029 · Cited by 93
Microspheres and drug therapy : pharmaceutical, immunological, and medical aspects
Davis, S. S. (1984) · Medical Entomology and Zoology · Cited by 92
Fillit, H. M., Hill, J. W., & Futterman, R. (2002) · PubMed · Cited by 91
Bayomi, M. A., Al‐Suwayeh, S. A., El-Helw, A. M., et al. (1998) · Pharmaceutica Acta Helvetiae · doi:10.1016/s0031-6865(98)00020-x · Cited by 91
Marchal‐Heussler, L., Maincent, P., Hoffman, M., et al. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90248-3 · Cited by 85
Schröeder, U., Schröeder, H., & Sabel, B. A. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00619-0 · Cited by 66
Drug and gene targeting to the brain via blood–brain barrier receptor-mediated transport systems
Pardridge, W. M. (2005) · International Congress Series · doi:10.1016/j.ics.2005.02.011 · Cited by 64
Stomach-specific anti-H. pylori therapy
Hejazi, R., & Amiji, M. M. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.12.001 · Cited by 57
Ciproflexacin-loaded polyisobutylcyanoacrylate nanoparticles: Preparation and characterization
Fawaz, F. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00138-5 · Cited by 38
The Burden of Dementia: A Medical and Research Perspective
Antuono, P., & Beyer, J. (1999) · Metamedicine · doi:10.1023/a:1009915605467 · Cited by 37
Devineni, D., Klein–Szanto, A. J., & Gallo, J. M. (1995) · Journal of Neuro-Oncology · doi:10.1007/bf01078484 · Cited by 37
Zhang, Z., Gongtie, L., Nagai, T., et al. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04550-4 · Cited by 34
Cited by
Transport of drugs across the blood–brain barrier by nanoparticles.
Wohlfart, S., Gelperina, S., & Kreuter, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.017 · Cited by 715
Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
Kreuter, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.008 · Cited by 554
Bhaskar, S., Tian, F., Stoeger, T., Kreyling, W., de la Fuente, J. M., Grazú, V., Borm, P., Estrada, G., Ntziachristos, V., & Razansky, D. (2010) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-7-3 · Cited by 495
Nanoparticles in Drug Delivery: From History to Therapeutic Applications
Afzal, O., Altamimi, A. S. A., Nadeem, M. S., Alzarea, S. I., Almalki, W. H., Tariq, A., Mubeen, B., Murtaza, B. N., Iftikhar, S., Riaz, N., et al. (2022) · Nanomaterials · doi:10.3390/nano12244494 · Cited by 468
Strategy for effective brain drug delivery
Alam, M. I., Beg, S., Samad, A., Baboota, S., Kohli, K., Ali, J., Ahuja, A., & Akbar, M. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.05.003 · Cited by 415
Metadata
- Authors
- WILSON, B., SAMANTA, M., SANTHI, K., KUMAR, K., PARAMAKRISHNAN, N., & SURESH, B.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 70
- Issue
- 1
- Pages
- 75-84
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W2075347200
- Cited by
- 278
- References
- 60
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.